throwing up after taking semaglutide Nausea: Why It Happens and How to Manage It I overdosed on a weight

With a growing population grappling with obesity and its associated health issues, the need for successful therapeutic interventions escalates, consequently boosting the adoption of GLP-1 agonist weight loss pharmaceuticals due to their established efficacy in facilitating weight loss and improving metabolic functions

Now, roughly 1 in 8 adults say theyve used a GLP-1 drug, and around 1 in 4 people with diabetes are now using GLP-1s as part of their care

Depending on glycaemic response and tolerability, the dose may be further increased to 1 mg weekly after at least four weeks, with a maximum licensed dose of 2 mg weekly available for those requiring additional glycaemic control after at least four weeks at the 1 mg dose

It is neither a simple cognitive enhancer nor a narrow-spectrum therapeutic